Benjamin Edwards Inc Invitae Corp Transaction History

Benjamin Edwards Inc

$6.71 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.42 - $0.72 $496 - $851	-1,183 Reduced 43.8%	1,518 $1,000
Q3 2023 Nov 13, 2023	BUY	$0.6 - $1.53 $16 - $41	27 Added 1.01%	2,701 $2,000
Q2 2023 Aug 15, 2023	BUY	$1.05 - $1.63 $79 - $123	76 Added 2.93%	2,674 $3,000
Q1 2023 Apr 27, 2023	BUY	$1.2 - $2.73 $156 - $354	130 Added 5.27%	2,598 $4,000
Q4 2022 Feb 07, 2023	BUY	$1.71 - $3.61 $831 - $1,754	486 Added 24.52%	2,468 $5,000
Q3 2022 Oct 28, 2022	SELL	$1.9 - $8.63 $77 - $353	-41 Reduced 2.03%	1,982 $5,000
Q2 2022 Aug 12, 2022	BUY	$2.13 - $9.01 $144 - $612	68 Added 3.48%	2,023 $5,000
Q1 2022 May 04, 2022	BUY	$6.28 - $15.59 $238 - $592	38 Added 1.98%	1,955 $16,000
Q4 2021 Feb 07, 2022	BUY	$14.7 - $28.67 $1,661 - $3,239	113 Added 6.26%	1,917 $29,000
Q3 2021 Nov 02, 2021	BUY	$24.31 - $33.6 $5,858 - $8,097	241 Added 15.42%	1,804 $51,000
Q2 2021 Aug 11, 2021	BUY	$26.09 - $40.4 $1,956 - $3,030	75 Added 5.04%	1,563 $53,000
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $1,090 - $1,878	33 Added 2.27%	1,488 $57,000
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $24,822 - $36,449	-635 Reduced 30.38%	1,455 $61,000
Q3 2020 Nov 16, 2020	SELL	$28.43 - $44.67 $3,610 - $5,673	-127 Reduced 5.73%	2,090 $91,000
Q1 2020 May 07, 2020	BUY	$7.64 - $27.5 $5,393 - $19,415	706 Added 46.72%	2,217 $30,000
Q4 2019 Feb 06, 2020	BUY	$15.02 - $20.57 $8,531 - $11,683	568 Added 60.23%	1,511 $24,000
Q3 2019 Nov 05, 2019	BUY	$18.85 - $27.5 $358 - $522	19 Added 2.06%	943 $18,000
Q2 2019 Aug 08, 2019	BUY	$17.37 - $26.27 $12,089 - $18,283	696 Added 305.26%	924 $22,000
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $2,428 - $5,871	228 New	228 $5,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

1.92M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Account